-
1
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is effective for various hematologic and metabolic disorders in pediatric patients.
-
2
Despite improved overall survival, treatment-related mortality (TRM) and vascular complications like CLS, TMA, and VOD remain significant challenges.
-
3
Vascular complications post-transplant are variable, complicating early detection and timely intervention, which are critical for patient outcomes.
-
4
This study analyzed 218 pediatric allo-HSCT patients to assess the incidence and clinical variation of acute vascular toxicity within 100 days post-transplant.
-
5
Key vascular complications were documented, with specific attention to endothelial dysfunction, highlighting the need for improved monitoring and management.
